Search results for "Short-chain fatty acids"

showing 6 items of 6 documents

Impact of a Plant Sterol- and Galactooligosaccharide-Enriched Beverage on Colonic Metabolism and Gut Microbiota Composition Using an In Vitro Dynamic…

2019

This document is he Accepted Manuscript version of a Published Work that appeared in final form in Journal of Agricultural and Food Chemistry, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://doi.org/10.1021/acs.jafc.9b04796

0106 biological sciencesmedicine.medical_treatmentButyrateGut flora01 natural scienceschemistry.chemical_compoundShort-chain fatty acidsmedicineFood science16S rRNA gene sequencingchemistry.chemical_classificationSterol metabolitesbiologyChemistryGalactooligosaccharidePrebiotic010401 analytical chemistryLachnospiraceaeGeneral ChemistryMetabolismbiology.organism_classificationSterol0104 chemical sciencesDynamic colonic fermentationPropionateLactateGeneral Agricultural and Biological Sciences010606 plant biology & botany
researchProduct

Gut Microbiota, Short-Chain Fatty Acids, and Herbal Medicines

2018

As an important source for traditional medical systems such as Ayurvedic medicine and traditional Chinese medicine, herbal medicines have received widespread attentions from all over the world, especially in developing countries. Over the past decade, studies on gut microbiota have generated rich information for understanding how gut microbiota shape the functioning of our body system. In view of the importance of gut microbiota, the researchers engaged in studying herbal medicines have paid more and more attention to gut microbiota and gut microbiota metabolites. Among a variety of gut microbiota metabolites, short-chain fatty acids (SCFAs) have received most attention because of their imp…

0301 basic medicineBody systemPharmacologyAyurvedic medicineTraditional medicinegut microbiotaMini Reviewshort-chain fatty acidslcsh:RM1-950Traditional Chinese medicineBiologyGut florabiology.organism_classificationdigestive system03 medical and health sciencestraditional Chinese medicine030104 developmental biologylcsh:Therapeutics. Pharmacologyherbal medicinesPharmacology (medical)metabolitesMedical systemsFrontiers in Pharmacology
researchProduct

Infant gut microbiota modulation by human milk disaccharides in humanized microbiome mice

2021

Human milk glycans present a unique diversity of structures that suggest different mechanisms by which they may affect the infant microbiome development. A humanized mouse model generated by infant fecal transplantation was utilized here to evaluate the impact of fucosyl-α1,3-GlcNAc (3FN), fucosyl-α1,6-GlcNAc, lacto-N-biose (LNB) and galacto-N-biose on the fecal microbiota and host–microbiota interactions. 16S rRNA amplicon sequencing showed that certain bacterial genera significantly increased (Ruminococcus and Oscillospira) or decreased (Eubacterium and Clostridium) in all disaccharide-supplemented groups. Interestingly, cluster analysis differentiates the consumption of fucosyl-oligosacc…

0301 basic medicineMaleBifidobacterium longuminfant fecal microbiotaMicrobiologiaRC799-869Gut floraAcetatesDisaccharidesFecesMice0302 clinical medicinelacto-n-biosefluids and secretionsRuminococcus gnavusRNA Ribosomal 16SEubacteriumgalacto-n–bioseBifidobacteriumbiologyGastroenterologyDiseases of the digestive system. Gastroenterologylacto-N-biosegalacto-N–biosefucosyl-α-1ButyratesInfectious Diseases030211 gastroenterology & hepatologyFemaleResearch ArticleResearch PaperMicrobiology (medical)AdultDNA Bacterialhumanized mouse modelInfants Malaltiesshort-chain fatty acidsMicrobiologyMicrobiology03 medical and health sciencesfucosyl-α-16-N-acetylglucosamineYoung AdultAnimalsHumans6-n-acetylglucosamineMicrobiomeBacteriaMilk HumanRuminococcusInfant NewbornInfantAkkermansiafucosyl-α-13-N-acetylglucosaminebiology.organism_classificationcytokinesGastrointestinal Microbiome3-n-acetylglucosamineMice Inbred C57BL030104 developmental biologyshort-chain fatty acidscytokineshuman milk oligosaccharides
researchProduct

A Weaning Reaction to Microbiota Is Required for Resistance to Immunopathologies in the Adult.

2019

International audience; Microbes colonize all body surfaces at birth and participate in the development of the immune system. In newborn mammals, the intestinal microbiota is first shaped by the dietary and immunological components of milk and then changes upon the introduction of solid food during weaning. Here, we explored the reactivity of the mouse intestinal immune system during the first weeks after birth and into adulthood. At weaning, the intestinal microbiota induced a vigorous immune response—a “weaning reaction”—that was programmed in time. Inhibition of the weaning reaction led to pathological imprinting and increased susceptibility to colitis, allergic inflammation, and cancer …

0301 basic medicinecolitis[SDV]Life Sciences [q-bio]short-chain fatty acidsImmunologyRetinoic acidTretinoinWeaningBiologyT-Lymphocytes Regulatoryregulatory T cellsAllergic inflammation03 medical and health scienceschemistry.chemical_compoundMice0302 clinical medicineImmune systemRAR-related orphan receptor gammamicrobiotamedicineImmunology and AllergyWeaningAnimalsinflammatory pathologyColitisImprinting (psychology)Intestinal Mucosaneonatal periodNuclear Receptor Subfamily 1 Group F Member 3medicine.diseaseFatty Acids Volatile3. Good healthGastrointestinal Microbiome[SDV] Life Sciences [q-bio]Mice Inbred C57BL030104 developmental biologyInfectious DiseaseschemistryAnimals NewbornSolid food030220 oncology & carcinogenesisImmunologymucosal immunityImmunity
researchProduct

Dietary Fats and Cardio-Metabolic Outcomes in a Cohort of Italian Adults

2022

Background: Dietary fats, and especially saturated fatty acid (SFA), have been blamed for being the culprit in the dramatic increase in obesity and its associated diseases. However multiple systematic reviews and recent meta-analyses do not support the association between SFA and cardiovascular diseases. Thus, the objective of this study was to test whether specific types and subtypes of dietary fats are associated with metabolic outcomes in a cohort of Italian adults. Methods: Nutritional and demographic data of 1936 adults living in the south of Italy were examined. Food frequency questionnaires (FFQs) were administered to assess the intake of total dietary fat and each specific class of …

Adultsaturated fatshort-chain fatty acidsVolatilemonounsaturated fatFatty Acids MonounsaturatedfatHumansSettore MED/49 - Scienze Tecniche Dietetiche Applicatesaturated fatspolyunsaturated fatUnsaturatedNutrition and Dieteticsshort-chain fatty acids.Fatty Acidspolyunsaturated fatsdietary fatsfat; dietary fats; saturated fats; polyunsaturated fats; monounsaturated fats; short-chain fatty acidsFatty Acids VolatileCarbonMonounsaturateddietary fatHypertensionFatty Acids Unsaturatedmonounsaturated fatsFood ScienceNutrients; Volume 14; Issue 20; Pages: 4294
researchProduct

The Metabolic Sensor GPR43 Receptor Plays a Role in the Control of Klebsiella pneumoniae Infection in the Lung

2018

Pneumonia is one of the leading causes of death and mortality worldwide. The inflammatory responses that follow respiratory infections are protective leading to pathogen clearance but can also be deleterious if unregulated. The microbiota is known to be an important protective barrier against infections, mediating both direct inhibitory effects against the potential pathogen and also regulating the immune responses contributing to a proper clearance of the pathogen and return to homeostasis. GPR43 is one receptor for acetate, a microbiota metabolite shown to induce and to regulate important immune functions. Here, we addressed the role of GPR43 signaling during pulmonary bacterial infection…

lcsh:Immunologic diseases. Allergy0301 basic medicinePhagocytosisshort-chain fatty acids030106 microbiologyImmunologyInflammationBiologyGut floraMicrobiology03 medical and health sciencesImmune systemmicrobiotamedicinepneumoniaImmunology and AllergyPathogenLunglung infectionGPR43biology.organism_classificationmedicine.disease030104 developmental biologymedicine.anatomical_structureinflammationIncreased inflammatory responsemedicine.symptomlcsh:RC581-607Pneumonia (non-human)Frontiers in Immunology
researchProduct